India Makes Clinical Research Comeback But Challenges Remain
This article was originally published in PharmAsia News
Executive Summary
Recent steps by the Indian government to streamline procedures for clinical trials are bringing a new glimmer of hope to the beleaguered industry. An improved framework now exists that puts India in a better place than pre-2010, however it may take more collaborative efforts to align India with international norms, says Gopalkrishna Pai, General Manager, George Clinical (India).